Multiple studies have demonstrated that C9orf72 RNA and protein levels are decreased in the brains and other tissues of ALS/FTD patients, who carry hundreds to thousands of the hexanucleotide repeats, when compared to normal individuals, who typically have only several repeats [12–16]. This evidence concerns the gene C9orf72 and frontotemporal dementia.